Auxilium Pharma Revenue Of $255-277M And Net Loss of $35-45M (AUXL)

by Gary Cassady, Benzinga Staff Writer
April 12, 2011 8:03 AM | 11 seconds read |
In a company 8-K Filing, Auxilium Pharma AUXL sees FY11 revenues of $255-277M vs. $268M estimates, and sees FY11 net income loss of $35-45M vs. a loss of $36M estimate.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsGuidanceHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!